The Medicines Company To Present Data At On Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE(Meropenem And Vaborbactam) - BioLegacy Research

The Medicines Company To Present Data At On Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE(Meropenem And Vaborbactam)

Post author:Sam
Post published:September 28, 2017
Post category:BioPharma

Life Sciences Jobs …
Source: BioSpace